Document Detail


Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature.
MedLine Citation:
PMID:  23283668     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Treatment of metastatic renal cell carcinoma has radically changed during the last decade with the approval of new drugs, antiangiogenic agents and mammalian targets of rapamycin (m-TOR) inhibitors. The outcome of metastatic clear-cell carcinoma has been significantly improved, while other entities such as metastatic papillary renal cell carcinoma are still associated with a poor prognosis. To date, there is no standard guideline for metastatic non clear cell carcinoma. We report the case of a 68-year-old patient with a pulmonary metastatic evolution of a papillary kidney cancer who has had more than 3 years disease progression-free survival and is under ongoing treatment with m-TOR inhibitors.
Authors:
Amaury Daste; Marine Gross-Goupil; Sophie Roca; Jean-Christophe Bernhard; Alain Ravaud
Related Documents :
23991038 - Luminal breast cancer cell lines overexpressing znf703 are resistant to tamoxifen throu...
24622438 - Expression of a constitutively active prolactin receptor causes histone trimethylation ...
24079198 - Chemical composition and biological activity of conyza bonariensis essential oil collec...
23838288 - Inhibition of vacuolar h+ atpase enhances sensitivity to tamoxifen via up-regulation of...
12147858 - Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast us i...
8390098 - Imaging lung cancer with radiolabeled antibodies.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-3
Journal Detail:
Title:  Targeted oncology     Volume:  -     ISSN:  1776-260X     ISO Abbreviation:  Target Oncol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101270595     Medline TA:  Target Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Medical Oncology, Hôpital Saint-André, Bordeaux, University Hospital-CHU Bordeaux, 1 Rue Jean Burguet, 33000, Bordeaux, France, amaury_daste@hotmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A description of the geological context, discrete traits, and linear morphometrics of the Middle Ple...
Next Document:  Pelvic flexion measurement from lateral projection radiographs is clinically reliable.